Literature DB >> 7903066

Analysis of the cytotoxic interaction between cisplatin and hyperthermia in a human ovarian carcinoma cell line.

E Kimura1, S B Howell.   

Abstract

Expression of the heat-shock protein HSP-60 is associated with poor survival in patients with ovarian carcinoma. We examined both the nature of the interaction between hyperthermia and cisplatin (DDP) using the human ovarian carcinoma cell line 2008 and the effect on this interaction of the induction of the heat-shock response. The nature of the interaction was assessed using median-effect analysis. Despite the observation that 45 degrees C hyperthermia increased the intracellular uptake of the DDP analog [3H]-cis-dichloro(ethylenediamine)platinum(II) (DEP) during a 1-h exposure by 155% +/- 55% (P = 0.02), median-effect analysis indicated only cytotoxic additivity (combination index at the level of 50% cell kill, 0.96 +/- 0.25). When cells were first exposed to hyperthermia for various periods and then allowed to incubate at 37 degrees C for 4 h to allow induction of the heat-shock genes before being treated with DDP for 1 h, there was a very small degree of antagonism between hyperthermia and DDP (combination index at 50% cell kill, 1.11 +/- 0.04). Our results indicate that DDP and hyperthermia interact only in an additive manner against this human ovarian carcinoma cell line and that the induction of heat-shock proteins by hyperthermia does not significantly antagonize the activity of DDP.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7903066     DOI: 10.1007/bf00685884

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  31 in total

1.  Cell-mediated immunity to human malignant cells. A brief review and further studies with two gynecologic tumors.

Authors:  P J DiSaia; J G Sinkovics; F N Rutledge; J P Smith
Journal:  Am J Obstet Gynecol       Date:  1972-12-01       Impact factor: 8.661

2.  Potential for therapy of drugs and hyperthermia.

Authors:  G M Hahn
Journal:  Cancer Res       Date:  1979-06       Impact factor: 12.701

3.  Characterization of the adducts produced in DNA by cis-diamminedichloroplatinum(II) and cis-dichloro(ethylenediamine)platinum(II).

Authors:  A Eastman
Journal:  Biochemistry       Date:  1983-08-02       Impact factor: 3.162

4.  In vitro modulation of cisplatin accumulation in human ovarian carcinoma cells by pharmacologic alteration of microtubules.

Authors:  R D Christen; A P Jekunen; J A Jones; F Thiebaut; D R Shalinsky; S B Howell
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

5.  Pharmacokinetics and toxicity of intraperitoneal cisplatin combined with regional hyperthermia.

Authors:  E L Zakris; M W Dewhirst; J E Riviere; P J Hoopes; R L Page; J R Oleson
Journal:  J Clin Oncol       Date:  1987-10       Impact factor: 44.544

6.  Correlation of the survival of ovarian cancer patients with mRNA expression of the 60-kD heat-shock protein HSP-60.

Authors:  E Kimura; R E Enns; J E Alcaraz; J Arboleda; D J Slamon; S B Howell
Journal:  J Clin Oncol       Date:  1993-05       Impact factor: 44.544

7.  Potentiation of platinum analogue cytotoxicity by hyperthermia.

Authors:  M J Xu; D S Alberts
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

8.  Effects of cytostatic drugs and 40.5 degrees C hyperthermia on human bone marrow progenitors (CFU-C) and human clonogenic tumor cells implanted into mice.

Authors:  H A Neumann; H H Fiebig; G W Löhr; R Engelhardt
Journal:  J Natl Cancer Inst       Date:  1985-12       Impact factor: 13.506

Review 9.  Clinical hyperthermia and chemotherapy.

Authors:  F K Storm
Journal:  Radiol Clin North Am       Date:  1989-05       Impact factor: 2.303

10.  Therapeutic synergism of hyperthermia-cis-platinum in a mouse tumor model.

Authors:  D S Alberts; Y M Peng; H S Chen; T E Moon; T C Cetas; J D Hoeschele
Journal:  J Natl Cancer Inst       Date:  1980-08       Impact factor: 13.506

View more
  4 in total

1.  Stimulated upregulation of HO-1 is associated with inadequate response of gastric and ovarian cancer cell lines to hyperthermia and cisplatin treatment.

Authors:  Vaidotas Cesna; Arturas Sukovas; Aldona Jasukaitiene; Giedre Silkuniene; Saulius Paskauskas; Zilvinas Dambrauskas; Antanas Gulbinas
Journal:  Oncol Lett       Date:  2019-06-18       Impact factor: 2.967

2.  Synergistic interaction between cisplatin and tamoxifen delays the emergence of cisplatin resistance in head and neck cancer cell lines.

Authors:  B Nakata; K D Albright; R M Barton; S B Howell; G Los
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

Review 3.  Pleiotropic role of HSF1 in neoplastic transformation.

Authors:  Natalia Vydra; Agnieszka Toma; Wieslawa Widlak
Journal:  Curr Cancer Drug Targets       Date:  2014       Impact factor: 3.428

4.  Overexpression of Heat Shock Transcription Factor 1 enhances the resistance of melanoma cells to doxorubicin and paclitaxel.

Authors:  Natalia Vydra; Agnieszka Toma; Magdalena Glowala-Kosinska; Agnieszka Gogler-Piglowska; Wieslawa Widlak
Journal:  BMC Cancer       Date:  2013-10-29       Impact factor: 4.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.